Cytokine expression profile of sensitized human T lymphocytes following in vitro stimulation with amoxicillin

European Cytokine Network

Volumn 19, Issue 3, 2008, Pages 131-141

  Khalil, Georges ^a   El Sabban, Marwan ^b   Al Ghadban, Sara ^b   Azzi, Sandy ^a   Shamra, Sara ^b   Khalifé, Simon ^a   Maroun, Richard ^a  

^a SAINT JOSEPH UNIVERSITY   (Lebanon)

^b AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

Author keywords

Cytokines; In vitro stimulation; Penicillin allergy; Sensitized lymphocytes

Indexed keywords

AMOXICILLIN; GAMMA INTERFERON; INTERLEUKIN 13; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; ANTIINFECTIVE AGENT; CYTOKINE; PENICILLIN DERIVATIVE;

ADULT; AGED; ARTICLE; CELL ISOLATION; CHEMOSENSITIZATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSPOT ASSAY; FEMALE; HUMAN; HUMAN CELL; LYMPHOCYTE ACTIVATION; LYMPHOCYTE CULTURE; MALE; MONONUCLEAR CELL; PENICILLIN ALLERGY; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; SUPERNATANT; T LYMPHOCYTE; ADOLESCENT; BLOOD; CELL CULTURE; CELL PROLIFERATION; CYTOLOGY; DRUG EFFECT; DRUG HYPERSENSITIVITY; GENE EXPRESSION PROFILING; GENETICS; METABOLISM; MIDDLE AGED;

ADOLESCENT; ADULT; AGED; AMOXICILLIN; ANTI-BACTERIAL AGENTS; CELL PROLIFERATION; CELLS, CULTURED; CYTOKINES; DRUG HYPERSENSITIVITY; FEMALE; GENE EXPRESSION PROFILING; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-13; INTERLEUKIN-2; INTERLEUKIN-4; INTERLEUKIN-5; MALE; MIDDLE AGED; PENICILLINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; T-LYMPHOCYTES; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR-ALPHA;

EID: 58149393115     PISSN: 11485493     EISSN: None     Source Type: Journal    
DOI: 10.1684/ecn.2008.0132     Document Type: Article

References (57)

1. MacLaughlin EJ, Saseen JJ, Malone DC. Costs of ß- lactam allergies. Arch Fam Med 2000; 9: 722-6.
2. Bigby M, Jick S, Jick H, et al. Drug induced cutaneous reactions: a report from the Boston Collaborative Drug Surveillance Program on 15, 438 consecutive inpatients, 1975-1982. JAMA 1986; 256: 3358-63.
3. Roujeau JC, Kelly JP. Severe adverse cutaneous reactions to drugs. N Eng l J Med 1994: 3311272-85.
4. Terrados S, Blanca M, Garcia J, et al. Non-immediate reactions to ß- lactams: prevalence and role of the different penecillins. Allergy 1995; 50: 563-7.
5. Descotes J, Choquet-Kastylevsky G. Gell and Coombs's classification: is it still valid? Toxicology 2001; 158: 43-9.
6. Cousin F, Catelain A, Philips K, et al. Immediate hypersensitivity is rarely implicated in drug-induced urticaria. Ann Dermatol Ve- nereol 2003; 130: 321-4.
7. Torres MJ, Blanca M, Fernandez J, et al. ENDA; EAACI Interest Group on Drug Hypersensitivity. Diagnosis of immediate allergic reactions to beta-lactam antibiotics. Allergy 2003; 58: 961-72.
8. Bircher AJ. Drug-induced urticaria and angioedema caused by non-IgE mediated pathomechanisms. Eur J Dermatol 1999; 9: 657-63.
9. Barbaud A, Reichert-Penetrat S, Trechot P, et al. The use of skin testing in the investigation of cutaneous adverse drug reactions. Br J Dermatol 1998; 139: 49-58.
10. Barbaud A, Gonçalo M, Bruynzeel D, et al. Guidelines for performing skin tests with drugs in the investigation of cutaneous adverse drug reactions. Contact Dermatitis 2001; 45: 321-8.
11. Sogn DD, Evans R, Shepherd GM, et al. Results of the National Institute of Allergy and Infectious Diseases Collaborative Clinical Trial to test the predictive value of skin testing with major and minor penicillin derivatives in hospitalized adults. Arch Intern Med 1992; 152: 1025-32; (lib).
12. Solley GO, Gleich GJ, Van Dellen RG. Penicillin allergy: clinical experience with a battery of skin-test reagents. J Allergy Clin Immunol 1982; 69: 238-44; (III).
13. Romano A, Viola M, Mondino C, et al. Diagnosing nonimmediate reactions to penicillins by in vivo tests. Int Arch Allergy Immunol 2002; 129: 169-74.
14. Torres MJ, Sanchez-Sabate E, Alvarez J, et al. Skin test evaluation in nonimmediate allergic reactions to penicillins. Allergy 2004; 59: 219-24.
15. Aberer W, Bircher A, Romano A, et al. Drug provocation testing in the diagnosis of drug hypersensitivity reactions: general considerations. Allergy 2003; 58: 854-63.
16. Grims RH, Kränke B, Aberer W. Pitfalls in drug allergy skin testing: false- positive reactions due to (hidden) additives. Contact Dermatitis 2006; 54: 290-4.
17. Matheu V, Perez E, Gonzalez R, et al. Assessment of a new brand of determinants for skin testing in a large group of patients with suspected ß- lactam allergy. J Investig Allergol Clin Immunol 2007; 17: 257-60.
18. Romano A, Blanca M, Torres MJ, et al. Diagnosis of nonimmedi- ate reactions to beta-lactam antibiotics. Allergy 2004; 59: 1153-60.
19. Sachs B, Al Massaoudi T, Merk HF, et al. Clinical and laboratory investigations. Combined in vivo and in vitro approach for the characterization of penicillin- specific polyclonal lymphocyte reactivity: tolerance tests with safe penicillins instead of challenge with culprit drugs. Br J Dermatol 2004; 151: 809-16.
20. Nyfeler B, Pichler WJ. The lymphocyte transformation test for the diagnosis of drug allergy: sensitivity and specificity. Clin Exp Allergy 1997; 27: 175-81.
21. Pichler WJ, Tilch J. The lymphocyte transformation test in the diagnosis of drug hypersensitivity. Allergy 2004; 59: 809-20.
22. Sanz ML, Gamboa PM, Antepara I, et al. Flow cytometric baso- phil activation test by detection of CD63 expression in patients with immediate-type reactions to betalactam antibiotics. Clin Exp Allergy 2002; 32: 277-86.
23. Beeler A, Pichler WJ. In vitro Tests of T-Cell-Mediated Drug Hypersensitivity. In: Pichler WJ, ed. Drug Hypersensitivity. Basel: Karger, 2007: 380-90.
24. Luque I, Leyva L, Jose Torres M, et al. In vitro T-cell responses to beta- lactam drugs in immediate and non-immediate allergic reactions. Allergy 2001; 56: 611-8.
25. Pichler WJ, Schnyder B, Zanni MP, et al. Role of T cells in drug allergies. Allergy 1998; 53: 225-32.
26. + T cells in individuals allergic to sulfona- mides, phenytoin and carbamazepine. J Immunol 1995; 155: 462.
27. Mosmann TR, Sad S. The expanding universe of T cell subsets: Th1, Th2 and more. Immunol Today 1996; 17: 138-46.
28. Chomarat P, Banchereau J. Interleukin-4 and Interleukin-13: their similarities and discrepancies. Int Rev Immunol 1998; 17: 1-52.
29. Hari Y, Frutig K, Hurni M, et al. T cell involvement in cutaneous drug eruptions. Clin Exp Allergy 2001; 31: 1398-403.
30. Yawalkar N, Egli F, Hari Y, et al. Infiltration of cytotoxic T cells in drug-induced cutaneous eruptions. Clin Exp Allergy 2000; 30: 847-55.
31. Pichler WJ, Yawalkar N, Britschgi M, et al. Pathophysiology of cutaneous drug reactions. Am J Clin Dermatol 2002; 3: 229-38.
32. Gaspard I, Guinnepain MT, Laurent J, et al. IL-4 and INF-γ mRNA induction in human peripheral lymphocytes specific for 6-lactam antibiotics in immediate or delayed hypersensitivity reactions. J Clin Immunol 2000; 20: 107-16.
33. Padovan E, Von Greyerz S, Pichler WJ, et al. Antigen-dependant and -independent IFN-γ modulation by penicillins. J Immunol 1999; 162:1171-7.
34. Sachs B, Erdmann S, Malte Baron J, et al. Determination of interleukin-5 secretion from drug-specific activated ex vivo peripheral blood mononuclear cells as test system for the in vitro detection of drug sensitization. Clin Exp Allergy 2002; 32: 736-44.
35. Macy E, Burchette RJ. Oral antibiotic adverse reactions after penicillin skin testing: multiyear follow- up. Allergy 2002; 57: 1151-8.
36. Blanca M, Vega JM, Garcia J, et al. Allergy to amoxicillin with good tolerance to other penicillins. Study of the incidence in patients allergic to 6-lactams. Clin Exp Allergy 1990; 20: 475-81.
37. Tas E, Pletscher M, Bircher AJ. IgE mediated urticaria from formaldehyde in a dental root canal compound. J Invest Allergol Clin Immunol 2002; 12: 130-3.
38. Blanca M, Vega JM, Gracia J, et al. New aspects of allergic reactions to betalactams: cross-reactions and unique specificities. Clin Exp Allergy 1994; 24: 407-15.
39. Torres MJ, Corzo JL, Leyva L, et al. Differences in the immuno- logical responses in drug- and virus- induced cutaneous reactions in children. Blood Cells Mol Dis 2003; 30: 124-31.
40. de Weck AL, Sanz ML. Flow cytometric cellular allergen stimulation test (FAST/FLOW-CAST) Technical and clinical evaluation of a new diagnostic test in allergy and pseudo-allergy. ACI Int 2002; 14: 204-15.
41. Moneret-Vautrin DA, Sainte Laudy J, Kanny J, et al. Human basophil activation measured by CD 63 expression and LTC4 release in IgE-mediated food allergy. Ann Allergy Asthma Immunol 1999; 82: 33-40.
42. Brugnolo F, Annunziato F, Sampognaro S, et al. Highly Th2- skewed cytokine profile of beta- lactam specific T- cells from non-atopic subjects with adverse drug reactions. J Immunol 1999; 163: 1053-9.
43. Juhlin L, Wide L. Detection of penicillin allergy by radioaller- gosorbent test. Lancet 1979; 2: 261.
44. Blanca Gomez M, Torres MJ, Mayorga C, et al. Immediate allergic reactions to betalactams: facts and controversies. Curr Opin Allergy Clin Immunol 2004; 4: 261-6.
45. Cederbrant K, Marcusson-Sta°hl M, Hultman P. Characterization of primary recall in vitro lymphocyte responses to bacampicillin in allergic subjects. Clin Exp Allergy 2000; 30: 1450-9.
46. Yawalkar N, Hari Y, Frutig K, et al. T-cells isolated from positive epicutaneous test reactions to amoxicillin and ceftriaxone are drug specific and cytotoxic. J Invest Dermatol 2000; 115: 652-64.
47. Kalish RS, LaPorte A, Wood JA, et al. Sulfonamide-reactive lymphocytes detected at very low frequency in the peripheral blood of patients with drug- induced eruptions. J Allergy Clin Immunol 1994; 94: 465-72.
48. Beeler A, Engler O, Gerber BO, et al. Long-lasting reactivity and high frequency of drug-specific T cells after severe systemic drug hypersensitivity reactions. J Allergy Clin Immunol 2006; 117: 455-62.
49. Sullivan KE, Cutilli J, Pieliero M, et al. Measurement of cytokine secretion, intracellular protein expression, and mRNA in resting and stimulated peripheral blood mononuclear cells. Clin Diagn Lab Immunol 2000; 7: 920-4.
50. Douglas SD, Durako S, Sullivan KE, et al. TH1 and TH2 cytokine mRNA and protein levels in human immunodeficiency(HIV)- seropositive and HIV seronegative youths. Clin Diagn Lab Immunol 2003; 10: 399-404.
51. Ledru E, Lecoeur H, Garcia S, et al. Differential susceptibility to activation-induced apoptosis among peripheral Th1 subsets: correlation with Bcl-2 expression and consequences forAIDS pathogen- esis. J Immunol 1998; 160: 3194-206.
52. Pichler WJ. Drug hypersensitivity reactions: classification and relationship to T- cell activation. In: Pichler WJ, ed. Drug Hypersen- sitivity. Basel: Karger, 2007: 168-89.
53. Posadas SJ, Leyva L, Torres MJ, et al. Subjects with allergic reactions to drugs show in vivo polarized patterns of cytokine expression depending on the chronology of the clinical reaction. J Allergy Clin Immunol 2000; 106: 769-76.
54. Roziéres A, Malcus C. Intérêt de la mesure par ELISPOT de la fréquence des LT spécifiques sécré teurs d'interféron gamma (IFN-γ) dans le diagnostic des toxidermies a l'amoxicilline. In: Anesthésie et allergie. Paris: John Libbey Eurotext, 2004: 49-53.
55. Lindemann M, Bohmer J, Zabel M, et al. Elispot: a new tool for the detection of nickel sensitization. Clin Exp Allergy 2003; 33: 992-8.
56. Schmittel A, Keilholz U, Bauer S, et al. Application of the IFN- gamma ELISPOT assay to quantify T cell responses against proteins. J Immunol Methods 2001; 247: 17-24.
57. McMichael AJ, O'Callaghan CA. A new look at T cells. J Exp Med 1998; 187: 1367-71.